JP6898617B2 - Ｐｒｄｍ１４発現を確認する方法 - Google Patents

Ｐｒｄｍ１４発現を確認する方法 Download PDF

Info

Publication number
JP6898617B2
JP6898617B2 JP2017185200A JP2017185200A JP6898617B2 JP 6898617 B2 JP6898617 B2 JP 6898617B2 JP 2017185200 A JP2017185200 A JP 2017185200A JP 2017185200 A JP2017185200 A JP 2017185200A JP 6898617 B2 JP6898617 B2 JP 6898617B2
Authority
JP
Japan
Prior art keywords
prdm14
cancer
subject
gene
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2017185200A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019060706A (ja
JP2019060706A5 (https=
Inventor
今井　浩三
浩三 今井
均 前佛
均 前佛
博昭 谷口
博昭 谷口
杏里 斎藤
杏里 斎藤
洋平 宮城
洋平 宮城
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tokyo NUC
Kanagawa Prefectural Hospital Organization
Original Assignee
University of Tokyo NUC
Kanagawa Prefectural Hospital Organization
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tokyo NUC, Kanagawa Prefectural Hospital Organization filed Critical University of Tokyo NUC
Priority to JP2017185200A priority Critical patent/JP6898617B2/ja
Priority to US16/650,415 priority patent/US20210208148A1/en
Priority to EP18861512.4A priority patent/EP3690444A4/en
Priority to PCT/JP2018/035395 priority patent/WO2019065609A1/ja
Publication of JP2019060706A publication Critical patent/JP2019060706A/ja
Publication of JP2019060706A5 publication Critical patent/JP2019060706A5/ja
Application granted granted Critical
Publication of JP6898617B2 publication Critical patent/JP6898617B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G01N2333/7158—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons for chemokines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2017185200A 2017-09-26 2017-09-26 Ｐｒｄｍ１４発現を確認する方法 Expired - Fee Related JP6898617B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2017185200A JP6898617B2 (ja) 2017-09-26 2017-09-26 Ｐｒｄｍ１４発現を確認する方法
US16/650,415 US20210208148A1 (en) 2017-09-26 2018-09-25 Method for confirming prdm14 expression
EP18861512.4A EP3690444A4 (en) 2017-09-26 2018-09-25 PROCEDURE FOR CONFIRMING EXPRESSION OF PRDM14
PCT/JP2018/035395 WO2019065609A1 (ja) 2017-09-26 2018-09-25 Ｐｒｄｍ１４発現を確認する方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017185200A JP6898617B2 (ja) 2017-09-26 2017-09-26 Ｐｒｄｍ１４発現を確認する方法

Publications (3)

Publication Number Publication Date
JP2019060706A JP2019060706A (ja) 2019-04-18
JP2019060706A5 JP2019060706A5 (https=) 2020-11-05
JP6898617B2 true JP6898617B2 (ja) 2021-07-07

Family

ID=65902885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017185200A Expired - Fee Related JP6898617B2 (ja) 2017-09-26 2017-09-26 Ｐｒｄｍ１４発現を確認する方法

Country Status (4)

Country Link
US (1) US20210208148A1 (https=)
EP (1) EP3690444A4 (https=)
JP (1) JP6898617B2 (https=)
WO (1) WO2019065609A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230127134A1 (en) * 2021-09-20 2023-04-27 Droplet Biosciences, Inc. Methods for cancer treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5219818B2 (https=) 1973-03-30 1977-05-31
WO2008038832A1 (en) * 2006-09-27 2008-04-03 Sapporo Medical University Therapeutic agent, detection method and detection kit for breast cancer and ovarian cancer
WO2011085163A2 (en) * 2010-01-08 2011-07-14 The Regents Of The University Of California Protein markers for lung cancer detection and methods of using thereof
WO2012054732A2 (en) * 2010-10-20 2012-04-26 Rush University Medical Center Lung cancer tests
JP6683986B2 (ja) * 2013-07-10 2020-04-22 国立大学法人 東京大学 がん幹細胞分子マーカー
US20150038365A1 (en) * 2013-08-01 2015-02-05 Meso Scale Technologies, Llc Lung cancer biomarkers
JP7136697B2 (ja) * 2015-09-25 2022-09-13 プロビスタ ダイアグノスティックス インコーポレイテッド デンスブレストを有する女性における乳癌の検出のためのバイオマーカー

Also Published As

Publication number Publication date
US20210208148A1 (en) 2021-07-08
EP3690444A4 (en) 2021-05-26
JP2019060706A (ja) 2019-04-18
WO2019065609A1 (ja) 2019-04-04
EP3690444A1 (en) 2020-08-05

Similar Documents

Publication Publication Date Title
JP4593557B2 (ja) 循環腫瘍細胞（ｃｔｃ）：転移癌患者における増悪までの時間、生存および療法に対する応答の早期評価
ES2492498T3 (es) Panel de biomarcadores para el diagnóstico y la predicción de rechazo de injerto
US20190292601A1 (en) Methods of diagnosing cancer using cancer testis antigens
KR102412396B1 (ko) 객담유래 세포의 dna 메틸화 표현형결정에 의한 조기 폐암 검출
KR101943177B1 (ko) 암 치료
EP3149209B1 (en) Methods for typing of lung cancer
US12195805B2 (en) Methods for subtyping of bladder cancer
JP2018512160A (ja) 肺がんのタイピングのための方法
JP2012527895A (ja) 被移植者における免疫寛容に伴うｂ細胞の特性
WO2019018764A1 (en) METHODS OF DETERMINING RESPONSE TO PARP INHIBITORS
US20120201750A1 (en) Serum biomarkers for melanoma metastasis
JP2026507052A (ja) 椎間板変性度の鑑別診断におけるｃｉｔｅｄ４及び／又はｍｅｔｒｎの使用
US20140371081A1 (en) Compositions for and Methods of Detecting, Diagnosing, and Prognosing Thymic Cancer
CN113234830A (zh) 用于肺癌诊断的产品及用途
JP6898617B2 (ja) Ｐｒｄｍ１４発現を確認する方法
KR101704828B1 (ko) 체액 내 세포밖 소포체의 단백질 또는 유전자 분석을 통한 염증성 질환 진단 방법
KR101895767B1 (ko) 동맥경화증 진단용 바이오 마커 조성물
TWI598444B (zh) 用以評估乳癌罹患風險之方法及基因標記
KR101815253B1 (ko) 간 섬유화 진단용 바이오마커 cxcl14
US20120156681A1 (en) Composition for diagnosis of liver metastasis of colorectal cancer and the use thereof
JP6949315B2 (ja) 肺扁平上皮癌と肺腺癌の鑑別評価方法
US20240182984A1 (en) Methods for assessing proliferation and anti-folate therapeutic response
CN110331207A (zh) 肺腺癌生物标志物及相关应用
KR102259695B1 (ko) 대장암에 대한 항암제 감수성 예측을 위한 신규 바이오마커
CN116445606A (zh) 血清分子标志物comp在辅助诊断抑郁症中的应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171003

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200915

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200915

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210401

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210412

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210506

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210603

R150 Certificate of patent or registration of utility model

Ref document number: 6898617

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees